|
|
Latest Filings
|
| View
|
Form
|
|
Filer
|
Received
|
Period
|
Download / Print
|
Actions
|
     |
SC 13D/A |
|
FORTRESS BIOTECH, INC. |
10/01/24 |
|
|
|
  |
| |
4 |
|
FORTRESS BIOTECH, INC. |
10/01/24 |
09/27/24 |
|
|
|
| |
EFFECT |
|
CHECKPOINT THERAPEUTICS, INC. |
09/03/24 |
|
|
|
|
| |
S-3 |
|
CHECKPOINT THERAPEUTICS, INC. |
08/19/24 |
|
|
|
|
  |
10-Q |
|
CHECKPOINT THERAPEUTICS, INC. |
08/12/24 |
06/30/24 |
|
|
|
| |
8-K |
|
CHECKPOINT THERAPEUTICS, INC. |
08/12/24 |
08/12/24 |
|
|
|
| |
8-K |
|
CHECKPOINT THERAPEUTICS, INC. |
07/25/24 |
07/25/24 |
|
|
|
| |
D |
|
CHECKPOINT THERAPEUTICS, INC. |
07/10/24 |
|
|
|
|
| |
8-K |
|
CHECKPOINT THERAPEUTICS, INC. |
07/03/24 |
06/28/24 |
|
|
|
| |
424B5 |
|
CHECKPOINT THERAPEUTICS, INC. |
07/03/24 |
|
|
|
|
|
|
|
|
|
Institutional Holders
|
|
|
Total Number of Holders
|
49
|
|
% of Shares Outstanding |
13.25%
|
|
Total Shares Held |
5,870,237
|
|
Total Value of Holdings |
$12,797,116.66
|
|
Net Activity |
366,522
|
|
|
|
|
|
Latest Company News
|
|
Date
|
|
|
|
|
|
|
(Quotes provided by Thomson Reuters are delayed by
15
minutes or more.)
|
|